baber/WOPTO huggingface dataset:
Patent CA-2476215-A1 (CA)
Title: Upgrading aluminide coating on used turbine engine component
Inventor: NGIAM SHIH-TUNG
IPC: C23G1/14
Filed: 2004-07-29
Abstract: A method of upgrading an aluminide coating on a used turbine engine component to a platinum aluminide coating. The method involves cleaning at least one surface of the component to remove hot corrosion products from the surface without damaging the aluminide coating. In one embodiment, the cleaning step involves immersing the component in a heated solution comprising acetic acid while agitating the solution using ultrasonic energy. A layer of platinum is then deposited onto the cleaned surface of the component. A second aluminide coating is then formed on the surface of the component to upgrade the component. The invention also relates to a turbine engine component, e.g., a turbine blade, having a metal-based substrate and a platinum aluminide coating on at least one surface thereof, which coating has been upgraded from an aluminide coating originally on the component using the above method.
Patent CA-2479700-A1 (CA)
Inventor: RAUKAS MADIS
IPC: C09K11/71
Filed: 2004-08-31
Abstract: A europium-activated barium aluminate phosphor is described wherein the phosphor is doped with tetravalent ions of Hf, Zr, or Si. Preferably, the phosphor is represented by (Ba1-x Eu x) MgAl10O17: (Hf, Zr, Si)y where 0. 05 <= x <= 0.25 and 0 < y <= 0.05. The tetravalent dopant ions are shown to enhance the stability of the phosphor in UV/VUV applications.
Patent CA-2480797-A1 (CA)
Title: Procede de production d'un systeme de protection contre la copie pour un circuit electronique
Inventor: MUND DIETRICH
IPC: H01L21/312
Filed: 2003-04-15
Abstract: L'invention vise, afin d'empêcher tout piratage d'un circuit de commutation intégré, de mettre au point un système contre la copie, qui soit efficace et fiable. Il est prévu un procédé comprenant les étapes suivantes : préparer un substrat (1) présentant des structures à semi-conducteurs (2) sur au moins une première face (1a) dudit substrat (1) ; préparer un matériau pour recouvrir ledit substrat (1) ; munir ledit substrat (1) d'une couche de protection contre la copie (4). Il s'est avéré particulièrement avantageux de produire la couche de protection contre la copie par dépôt par vaporisation d'un verre de silicate, du fait qu'ainsi, un procédé de gravure qui dissout la couche de protection contre la copie, attaque également le substrat (1), de sorte que les structures à semi-conducteurs (2) soient en partie détruites.
Patent CA-2482021-A1 (CA)
Inventor: DOANE SUZANN K
IPC: A61K41/00
Filed: 2003-04-24
Abstract: The methods of this invention involve preventing the formation of a complex between adenine and riboflavin by reducing the amount of adenine in a solution containing blood or blood components to be pathogen reduced.
Patent CA-2484162-A1 (CA)
Title: Imidazo-triazine derivatives as ligands for gaba receptors
Inventor: STREET LESLIE JOSEPH
IPC: C07D487/04
Filed: 2003-05-01
Abstract: A class of 7-phenylimidazo[1,2-b][1,2,4]triazine derivatives, substituted at the meta position of the phenyl ring by an optionally substituted aryl or heteroaryl group which is directly attached or bridged by an oxygen atom or a -NH- linkage, and substituted on the phenyl ring by one or two further substituents as defined herein, being selective ligands for GABAA receptors, in particular having good affinity for the .alpha.2 and/or .alpha.3 and/or .alpha.5 subunit thereof, are accordingly of benefit in the treatment and/or prevention of adverse conditions of the central nervous system, including anxiety, convulsions and cognitive disorders.
Patent CA-2486337-A1 (CA)
Title: Single reactor synthesis of koh-capped polyols based on dmc-synthesized intermediates
Inventor: KAUSHIVA BRYAN D
IPC: C08G65/32
Filed: 2004-10-29
Abstract: The present invention relates to processes for preparing ethylene oxide (EO)-capped polyols in which removal of catalyst residues or salts formed by the neutralization of the basic catalyst is not required prior to discharging the polyol from the reactor because neutralization occurs during or after the starter charge of a subsequent batch. The inventive processes allow for the preparation of DMC-catalyzed intermediates and their base-catalyzed EO caps within the same reactor. Polyols produced by the processes of the invention have a high content of primary hydroxyl groups and may be useful for producing polyurethane foams, elastomers, sealants, coatings, adhesives and the like.
Patent CA-2487996-A1 (CA)
Inventor: SCHWARTZ DONALD F
IPC: A61M5/145
Filed: 2003-06-04
Abstract: A syringe plunger driver system capable of capturing syringes of widely varying sizes comprises a pair of asymmetric plunger retainer arms pivotally mounted to a plunger driver. The system includes a low profile driver having a length that exceeds its width so that it may be mounted adjacent control modules and other operational modules. The arms are biased toward each other and one arm is longer than the other with a notch on an inside edge to recei ve the tip of the shorter arm when capturing small syringe flanges. A rotation knob mounted to the front surface of the low profile driver forces the arms apart when rotated to a first rotation position. A force sensor is mounted i n the driver to detect occlusions in the fluid line. A processor monitors the force sensed by the force sensor and provides an alarm if the force exceeds a threshold. The driver includes a force concentrator that defines a pushing surface adapted to press against a plunger flange so that the force applied to the plunger flange is concentrated at a defined location for more accurate measurement.
Patent CA-2492209-A1 (CA)
Inventor: LEBLANC WILSON ANDREW JR
IPC: E21B/
Filed: 2003-07-09
Abstract: L'invention concerne un dispositif de manipulation tubulaire, qui comprend un premier coin de retenue présentant une face intérieure arquée munie d'une première fente longitudinale dans laquelle est logée une première saillie. Un deuxième coin de retenue est raccordé au premier coin de retenue et présente une face intérieure arquée munie d'une deuxième fente longitudinale dans laquelle est logée une deuxième saillie. Un troisième coin de retenue est raccordé au deuxième coin de retenue et présente une face intérieure arquée munie d'une troisième fente longitudinale dans laquelle est logée une troisième saillie. Le dispositif comprend en outre une première pièce rapportée qui présente un premier épaulement et est configurée pour s'adapter à l'intérieur de la première saillie, ladite première pièce rapportée pouvant transférer une charge du premier épaulement à la première saillie. Une deuxième pièce rapportée présentant un deuxième épaulement est configurée pour s'adapter à l'intérieur de la deuxième saillie, ladite deuxième pièce rapportée pouvant transférer la charge du deuxième épaulement à la deuxième saillie. Une troisième pièce rapportée présentant un troisième épaulement est configurée pour s'adapter à l'intérieur de la troisième saillie, ladite troisième pièce rapportée pouvant transférer la charge du troisième épaulement à la troisième saillie. Les coins de retenue peuvent comprendre plusieurs saillies configurées pour coopérer avec plusieurs épaulements garnissant les pièces rapportées, de sorte que la charge soit transférée des épaulements aux saillies. Dans un mode de réalisation, les saillies présentent une surface inclinée coopérant avec un angle complémentaire des épaulements. L'invention concerne en outre un procédé de manipulation d'éléments tubulaires sur une plate-forme de forage.
Patent CA-2494109-A1 (CA)
Inventor: WADENBERG MARIE-LOUISE
IPC: A61P25/00
Filed: 2003-07-28
Abstract: Cette invention concerne de nouvelles thérapies antipsychotiques et des compositions utiles dans la mise en oeuvre de ces thérapies ainsi que des procédés d'identification de nouvelles molécules candidates pour le traitement de psychoses faisant intervenir les affinités de liaison proportionnelles pour des récepteurs¿?.alpha.¿2? adrénergiques et D¿2? de dopamine.
Patent CA-2494939-A1 (CA)
Title: Controller for dispensing products
Inventor: INABNET JOSEPH
IPC: G06F19/00
Filed: 2003-08-08
Abstract: A controller is disclosed for use in a product dispensing system of the type having dispensing locations and validation devices. The controller comprises a memory containing linked information and containing a plurality of drivers, and a processor responsive to the input device and the memory for selecting an address based on the received information and the linked information. The processor (i) elects a driver from the plurality of drivers if the address corresponds to an automated dispensing device and (ii) produces an output responsive to the address if the address corresponds to a non-automated dispensing device.
Patent CA-2496227-A1 (CA)
Title: Liquid gel automatic dishwashing detergent composition comprising anhydrous solvent
Inventor: WAITS LESLIE DAWN
IPC: C11D7/12
Filed: 2003-08-20
Abstract: An organic solvent composition suitable for use in automatic dishwashing comprising: (a) from about 10% to about 80%, by weight, a non-aqueous organic solvent system; (b) from about 5% to about 70%, by weight, sodium tripolyphosphate (STPP); (c) at least about 0.00005%, by weight, a water-soluble dye; (d) an effective amount of water; (e) from about 0.5% to about 1%, by weight, a thickener; and (f) optionally an adjunct ingredient; wherein said composition is in the form of an anhydrous liquid gel; wherein the yield value of said composition has a range of from about 5 to about 35; and wherein the effective amount of water is calculated by the following formula: STPP + 6 H2O .fwdarw. STPP*6H2O.
Patent CA-2497984-A1 (CA)
Title: Cellular communications system for providing non-real time subscription data and related methods
Inventor: GRIFFIN JASON TYLER
IPC: H04W8/20
Filed: 2005-02-23
Abstract: A cellular communications system may include a plurality of mobile cellular communications devices each associated with a respective user, and at least one cellular base station for wirelessly communicating with the mobile cellular communications devices. The at least one cellular base station may have a capacity associated therewith. The system may also include a central station for determining available capacity of the at least one cellular base station based upon active wireless communications with the mobile cellular communications devices. Moreover, the system may also include a subscription server for cooperating with the central station to provide non-real time subscription data to users on respective mobile cellular communications devices via the at least one cellular base station when the determined available capacity thereof is greater than a threshold.
Patent CA-2498798-A1 (CA)
Title: Formulation opioides a liberation prolongee et procedes d'utilisation connexes
Inventor: BOEHM GARTH
IPC: A61K9/22
Filed: 2003-09-22
Abstract: Selon la présente invention, deux sous-unités différentes sont combinées avec différents profils de libération dans des formes dosifiées orales à libération soutenue. Notamment, les formes dosifiées orales renferment une sous-unité qui contient un analgésique opioïde et une matière à libération soutenue. Le taux de dissolution in vitro de la sous-unité, lorsqu'il est mesuré par le test de libération de médicament normalisé de l'USP de (2003) <724> de la Pharmacopée des Etats-unis XXVI, est inférieur à environ 10 % en l'espace d'environ 6 heures et d'au moins environ 60 % en l'espace d'environ 24 heures, inférieur à environ 10 % en l'espace d'environ 8 heures et d'au moins 60 % en l'espace d'environ 24 heures, inférieur à environ 10 % en l'espace d'environ 10 heures et d'au moins environ 60 % en l'espace d'environ 24 heures ou inférieur à environ 10 % en l'espace d'environ 12 heures et d'au moins environ 60 % en l'espace d'environ 24 heures, la forme dosifiée produisant une durée de l'effet thérapeutique d'environ 24 heures.
Patent CA-2502378-A1 (CA)
Inventor: KANG LING-LING
IPC: A61K9/00
Filed: 2003-10-28
Abstract: La présente invention concerne des particules polypeptidiques solides contenant un matériau polypeptidique qui est stabilisé contre une dégradation à des températures proches des conditions physiologiques ou les dépassant. Dans chaque mode de réalisation, les particules polypeptidiques de cette invention incorporent un matériau polypeptidique qui est stabilisé contre une dégradation par une ou plusieurs conditions stabilisantes. Comme les particules polypeptidiques de cette invention peuvent être préparées pour combiner les effets additifs d'au moins deux conditions stabilisantes, lorsque ces particules polypeptidiques comprennent un sucre stabilisant, la quantité de sucre stabilisant nécessaire pour obtenir une stabilité suffisante est considérablement réduite.
Patent CA-2505342-A1 (CA)
Inventor: JUNG GUNDRAM
IPC: C07K16/30
Filed: 2002-11-09
Abstract: A first bispecific antibody molecule comprises at least one binding site with a variable domain on a light chain (V<SB>L</SB>) and a variable domain for the T-cell receptor CD-28, linked thereto on a heavy chain (Vh). The antibody molecule further comprises at least one binding site with a variable domain on a heavy chain (V<SB>H</SB>) and a variable domain for a tumour antigen, linked thereto on a light chain (V<SB>L</SB>). The variable domains on the heavy chains for both specificities are connected to each other by means of a peptide linker. A second bispecific antibody molecule is bivalent for CD-28 and at least monovalent for the tumour antigen.
Patent CA-2505964-A1 (CA)
Title: Pharmaceutical compositions and dosage forms of thalidomide
Inventor: D ANGIO PAUL
IPC: A61K31/454
Filed: 2003-11-13
Abstract: Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable prodrugs, salts, solvates, hydrates, or clathrates are disclosed. Also disclosed are methods of treating and preventing diseases and conditions such as, but not limited to, leprosy, chronic graft-vs-host disease, rheumatoid arthritis, sarcoidosis, an inflammatory condition, inflammatory bowel disease, and cancer using the novel dosage forms disclosed herein.
Patent CA-2506371-A1 (CA)
Title: Method and system for multiplying the repetition rate of a pulsed laser beam
Inventor: WANG SHAMINO Y
IPC: H04B10/02
Filed: 2005-05-04
Abstract: A system and method for increasing a repetition rate of an optical pulse train. The system includes a pulsed source configured to generate the optical pulse train and a cyclic demultiplexer configured to process the optical pulse train and output an output optical pulse train on each of a number of output ports. Each of the output optical pulse trains has a final repetition rate that is a multiple of the repetition rate corresponding to the optical pulse train generated by the pulsed source.
Patent CA-2509597-A1 (CA)
Title: Coolant based on azole derivatives containing 1,3-propanediol for fuel cell cooling systems
Inventor: FLAIG BIRGIT
IPC: H01M8/04
Filed: 2003-12-03
Abstract: Antifreeze concentrates for cooling systems in fuel cell drives, from which ready-to-use aqueous coolant compositions having a conductivity of not more than 50 µS/cm result, based on 1,3--propanediol or mixtures of 1,3-propanediol with alkylene glycols and/or derivatives thereof, containing one or more five-membered heterocyclic compounds (azole derivatives) having 2 or 3 hetero atoms from the group consisting of nitrogen and sulfur, which contain no sulfur atom or not more than one sulfur atom and which may carry an aromatic or saturated six-membered fused moiety.
Patent CA-2510676-A1 (CA)
Title: Distribution of services software in a network
Inventor: SADIO WAQAR
IPC: G06F9/445
Filed: 2004-01-23
Abstract: Services in a data processing system and data processing sysetm network are composed, configured, deployed, and managed. This system provides deployment domains (300) to define a logical set of business services that have similar requirements for an application infrastructure. A deployment domain (300) is created, and a graphical user interface (500) allows a user to compose (210), configure (215), deploy (220), and manage (225) services within the deployment domain (300) and associated hosts using a drag-and-drop interface. A system and method for distributing and updating services software in the network and configuring heterogeneous underlying web services hosting platforms are claimed.
Patent CA-2512558-A1 (CA)
Title: Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes by increasing the number of islets of langerhans cells
Inventor: AUTIER VALERIE
IPC: A61K31/22
Filed: 2003-12-18
Abstract: The present invention relates to the use of at least one compound with inhibitory activity on kynurenine 3-hydroxylase, for the preparation of a medica ment for increasing the number of islets of Langerhans cells, which is intended especially for the prevention and/or treatment of diabetes.
Patent CA-2513009-A1 (CA)
Inventor: LICK JUERGEN
IPC: B64B1/40
Filed: 2003-01-10
Abstract: L'invention concerne un dispositif permettant de retransmettre un faisceau lumineux à l'enveloppe d'un aéronef. Ce dispositif comprend une source lumineuse destinée à la production d'un faisceau lumineux et au moins un dispositif de projection destiné à transformer le faisceau lumineux en faisceau lumineux apte à la projection. Le ou les dispositif(s) de projection situé(s) à l'intérieur de l'enveloppe est/sont disposé(s) de manière à projeter le faisceau lumineux sur l'enveloppe (60) via l'intérieur (15). L'enveloppe est au moins partiellement transparente pour permettre au faisceau lumineux projeté d'être visible à l'extérieur. L'invention concerne également un procédé de retransmission d'un faisceau lumineux à l'enveloppe d'un aéronef.
Patent CA-2515013-A1 (CA)
Title: Demulsification of emulsions by oscillatory mixing
Inventor: VARADARAJ RAMESH
IPC: C10G33/04
Filed: 2004-02-10
Abstract: The invention includes a method for demulsification of water-inoil emulsions, oil-in-water emulsions, and mixtures of water-in-oil and oil-inwater emulsions by oscillatory mixing of the emulsions.
Patent CA-2516128-A1 (CA)
Title: Therapeutic targets in cancer
Inventor: MORRIS DAVID W
IPC: C12Q1/68
Filed: 2004-02-17
Abstract: The present invention relates to novel sequences for use in detection, diagnosis and treatment of cancers, especially lymphomas. The invention provides cancer-associated (CA) polynucleotide sequences whose expression is associated with cancer. The present invention provides CA polypeptides associated with cancer that are present on the cell surface and present novel therapeutic targets against cancer. The present invention further provides diagnostic compositions and methods for the detection of cancer. The present invention provides monoclonal and polyclonal antibodies specific for the CA  polypeptides. The present invention also provides diagnostic tools and therapeutic compositions and methods for screening, prevention and treatment of cancer.
Patent CA-2516696-A1 (CA)
Title: Lip implant and method for insertion
Inventor: RAPHAEL PETER
IPC: A61B17/34
Filed: 2004-03-05
Abstract: A lip implant (10) and lip instrument (20). The lip implant (10) may be formed from materials such as solid silicone and urethane and is shaped to be received in the lip (44) of a patient. The lip instrument (20) includes a pair of arms (22aA,22b) coupled together having clamping members (32a,32b) to grasp and retain the lip implant (10). A method for insertion of the lip implant (10) into the patient is further described.
Patent CA-2520659-A1 (CA)
Title: Method and system for automatic portfolio monitoring
Inventor: SCHMELZ BARBARA L
IPC: G06Q40/00
Filed: 2004-03-04
Abstract: A portfolio monitoring and alerting service is available over the web that is user-friendly and easy to maintain. This service allows each user to monitor a portfolio of accounts on customers and suppliers containing business and financial information and observe changes to individual accounts within the portfolio, to manage the portfolio by adding or deleting accounts, to receive notice of and view alerts, and to receive notices for report renewal.
Patent CA-2521194-A1 (CA)
Inventor: PIROVIC ARPAD L
IPC: H01J19/70
Filed: 2004-03-31
Abstract: A germicidal lamp (18) having amalgam (44; 144) for controlling mercury vapor pressure contained in a location facilitating efficient high output operation.  A low pressure mercury vapor discharge lamp (18) has an amalgam container (46;  146) containing an. amalgam (44; 144) positioned behind an electrode (42; 142) out of the arc path or space. The amalgam position is retained during high wall loading of the lamp preventing the amalgam from moving out of position.  Efficient operation with high current loads and resulting high wall loading and temperatures is possible. The germicidal lamp (18) is particularly suited to being positioned vertically in a waste water treatment system (10).
Patent CA-2524921-A1 (CA)
Inventor: WAYNE DITTRICH D O
IPC: A61K31/405
Filed: 2004-08-05
Abstract: The present invention relates to a method and composition for treating sunburned skin. The present invention provides a method and composition for applying a mixture of indomethacin and moisturizing lotion topically to sunburned skin. The composition includes a mixture having substantially 100 milligrams of indomethacin per 30 cc of moisturizing lotion. The moisturizing lotion is marketed under the trade name Cetaphil® and includes the following ingredients: purified water, glycerin, hydrogenated polyisobutene, cetearyl alcohol (and) ceteareth-20, macadamia nut oil, dimethicone, tocopheryl acetate, stearoxytrimethylsilane (and) stearyl alcohol, panthenol, farnesol, benzyl alcohol, phenoxyethanol, acrylates/C10-30 alkyl acrylate crosspolymer, sodium hydroxide, and citric acid. It is theorized that the Cetaphil® provides certain pH and viscosity levels which allow for the stabilization and solubilation of the indomethacin within the Cetaphil®.  The present invention may also be utilized for treating skin burns caused by radiation therapy and excessive heat.
Patent CA-2526083-A1 (CA)
Inventor: NUNN MILES ANDREW
IPC: G01N33/68
Filed: 2004-06-02
Abstract: The invention relates to complement inhibitors that inhibit both the classical and alternative complement pathways. In particular, the invention relates to complement inhibitors derived from the salivary glands of haematophagous arthropods that inhibit both the classical and alternative complement pathways. The invention also relates to the use of such complement inhibitors in the treatment and prevention of diseases.
Patent CA-2528183-A1 (CA)
Title: Methods and apparatus for transmitting user selections to a host location in an interactive communication system
Inventor: POPA OVIDIU OCTAVIAN
IPC: H04N7/173
Filed: 2005-11-28
Abstract: A method for execution by customer equipment capable of communication with a user. The method comprises collecting user data, storing the user data in a memory scheduling execution of a data send application at a time later than the current time. The data send application comprises computer-readable instructions for causing transmission of the user data to a host. The data send application may be downloaded into the memory, or it may already reside in the memory before the user data is collected. Also, there is disclosed a customer device, with a user interface for collecting user data, a memory and a control unit adapted to execute computer-readable instructions for storing the collected user data into the memory and scheduling execution of a data send application at a time later than the current time. Thus, the transmission of votes and other information can be delayed until a time frame where resource usage is statistically lower.